Bright Minds Biosciences Inc. (DRUG) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bright Minds Biosciences ...

    NASDAQ: DRUG · Real-Time Price · USD
    48.75
    -0.63 (-1.28%)
    At close: Sep 12, 2025, 3:59 PM
    48.75
    0.00%
    After-hours: Sep 12, 2025, 04:57 PM EDT

    Bright Minds Biosciences Ratios and Metrics

    Financials in CAD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    PE Ratio
    		 -2.43 -1.1 -1.4 -9.39
    PEG Ratio
    		 0.04 0.02 -0.05 -0.01
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 1.23 1.22 1.99 4.19
    P/FCF Ratio
    		 -3.69 -1.15 -1.55 -11.1
    P/OCF Ratio
    		 -3.69 -1.15 -1.55 -11.1
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.02 0.01 0.01 n/a
    Quick Ratio
    		 11.32 24.26 8.11 31.38
    Current Ratio
    		 11.32 24.26 8.11 31.38
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.51 -1.12 -1.42 -0.45
    Return on Assets
    		 -0.46 -1.07 -1.24 -0.43
    Return on Invested Capital
    		 -0.46 -1.08 -1.38 -0.44
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist